Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

132
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
132
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

114
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
114
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

157
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
157
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

166
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
166

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-event pathways to 6-month death or dependency after ischemic stroke: Secondary analysis of the international stroke trial.

Journal of the neurological sciences·2026
Same author

Eye-Tracking Technologies for Cognitive Assessment After Acquired Brain Injury: Systematic Review.

JMIR rehabilitation and assistive technologies·2026
Same author

Molecular biomarkers of cognitive impairment and neuropsychiatric symptoms after stroke in late-life-enriched cohorts: a scoping review.

Journal of translational medicine·2026
Same author

Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: Rationale and Study Protocol of a Multicenter, Randomized, Proof-of-Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy (DOWN-SUITE).

Stroke (Hoboken, N.J.)·2026
Same author

Advanced, pharmacological and complementary interventions for chronic or recurrent orofacial pain conditions: a systematic evidence map with selective meta-analyses.

The journal of headache and pain·2026
Same author

Good Recovery, Poor Participation? A Secondary Analysis of the Dissociation Between Global Disability and Real-Life Participation Five Years After Traumatic Brain Injury.

Medical sciences (Basel, Switzerland)·2026

Related Experiment Video

Updated: Nov 19, 2025

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.2K

Meralgia Paresthetica Successfully Treated with Palmithoylethanolamide.

Rocco Salvatore Calabrò1,2,3,4, Carmela Casella1,2,3,4, Alfredo Manuli1,2,3,4

  • 1Drs. Calabrò and Manuli are with IRCCS Centro Neurolesi "Bonino Pulejo" in Messina, Italy.

Innovations in Clinical Neuroscience
|February 1, 2021
PubMed
Summary

Palmitoylethanolamide (PEA) effectively treated a patient with meralgia paresthetica (MP), a nerve entrapment condition. This suggests PEA may be a viable non-surgical option for peripheral neuropathies like MP.

Keywords:
Polyneuropathyinflammationnutraceuticals

More Related Videos

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
06:13

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain

Published on: March 1, 2024

1.4K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.4K

Related Experiment Videos

Last Updated: Nov 19, 2025

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.2K
Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
06:13

Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain

Published on: March 1, 2024

1.4K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.4K

Area of Science:

  • Neurology
  • Pain Management
  • Pharmacology

Background:

  • Meralgia paresthetica (MP) is an uncommon entrapment mononeuropathy causing thigh numbness and paresthesia.
  • Palmitoylethanolamide (PEA) is recognized for its therapeutic effects in chronic pain and neuropathic conditions.

Observation:

  • A case study involved a 28-year-old patient experiencing posttraumatic MP for three months.
  • The patient was otherwise healthy, indicating MP as the primary condition.

Findings:

  • Successful treatment of MP was achieved using Palmitoylethanolamide (PEA) at a dosage of 1200mg/day.
  • The patient experienced symptom resolution, indicating PEA's efficacy in managing MP.

Implications:

  • PEA demonstrates potential as a therapeutic agent for peripheral neuropathies, including meralgia paresthetica.
  • Further research into PEA for neuropathies could lead to non-invasive treatment alternatives, potentially avoiding surgery.